Generative AI in Drug Discovery Market 2022–2035 – Global Market Size, Industry Analysis, Segmental Insights, Regional Overview, Company Share Analysis, and Market Forecast

The global Generative AI in Drug Discovery market was valued at approximately USD 1.6 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 28.4% from 2025 to 2035, reaching around USD 24.7 billion by the end of the forecast period. The historical analysis starts from 2020 to 2023 with 2024 as the base year and forecasts starts from 2025 to 2035.

Generative AI in Drug Discovery Market is currently experiencing a surge of growth as more companies are demanding faster, cost-effective drug development cycles. Generative AI systems can be used to discover new drug candidates, optimize molecule structures, and predict therapeutic efficacy, making the development of new drugs faster and cheaper. The Generative AI Trends in Drug Discovery suggest a high level of uptake in biotechnology and pharmaceutical firms that need to generate innovation in the field of precision medicine. Regulatory & Policy Overview endorses AI-based approaches, which enable smooth approvals. North America is the overpowering region and APAC has been the most rapid in its adoption owing to an expansion in pharmaceutical R&D expenditure.

Introduction
Generative AI in Drug Discovery Market Report highlights how artificial intelligence may revolutionize drug research nowadays. Algorithms that run on AI create new molecular structures, estimate interactions, and allow in silico testing, thus minimising reliance on conventional trial and error methods. Generative AI in Drug Discovery Technology Adoption Technology Adoption in Generative AI is rapidly growing in the pharma and biotech industries with scalable and predictive solutions. The Market Dynamics point to the increasing necessity in the cost-effective, accurate, and fast drug development processes. This market provides computational efficiency with experimental validation, promoting new therapeutic discoveries and increasing opportunities in making investments.

Key Drivers: What’s Fueling the Generative AI in Drug Discovery Market Boom?

• Patients and medical professionals Accelerated Drug Development: Generative AI algorithms can accelerate drug discovery by forecasting of molecular structure and optimization of lead compounds. Classical methods of discovery are usually time-consuming, costly, and can require years to develop, but AI-driven solutions can decrease development time by a long margin. The analysis of the drug Discovery Industry Analysis Generative AI tells that early candidate screening and simulation helps decrease the number of experiments that failed and therefore companies are able to enter the market more quickly and enhance the ROI.
• Precision Medicine and Personalized Therapy: Generative AI can be used to develop personalized medicines based on the unique genomic and proteomic data of patients. Generative AI in Drug Discovery Technology Adoption enables predictive models to be focused on diseases with greater precision to enhance therapeutic outcomes. The trend is especially common in oncology and rare diseases, which provide a new opportunity to both biotech startups and well-established pharmaceutical companies.

Note: Charts and figures are illustrative only. Contact us for verified market data.

Innovation in Focus: How Manufacturers Are Raising the Bar?
In Drug Discovery Market Report, the innovations of generative AI include molecular generators powered by AI, protein structure prediction using deep learning, and multi-omics data integration. AI on the cloud can be used to conduct research and scale simulations. Pharma companies and startups are working on hybrid AI models to optimize drug-likeness, predict toxicity, and simulate clinical trial effects, becoming more efficient and accurate in drug pipeline. Such inventions are defining the future of personalized medicine and allowing discoveries of the next generation of therapeutics.

Recent Developments:
In 2024, Exscientia also introduced the next-generation AI drug discovery platform that incorporates deep learning to multi-target optimization. Recursion Pharmaceuticals increased collaboration with the major pharmaceutical corporations in order to speed up AI-preclinical screening of drugs.

Conclusion
Generative AI in Drug Discovery Market Report highlights how it has provided a revolutionary effect in speeding up drug discovery, lowering costs, and providing precision medicine. The major trends consist of generative models with AI, predictive analytics, and hybrid platforms. Pharmaceutical and biotechnology adoption, technological innovation and favorable regulatory frameworks drive the growth of the market. The market share is the highest in North America, but APAC is the fastest growing. As more and more people collaborate, invest, and use the technology, the market has a long-term growth, offering efficient, data-driven, and scalable solutions to the current problems of developing therapeutics.

The Drug Discovery Industry Analysis Generative AI demonstrates the presence of competitive market, strategic collaborations, partnerships and technological innovations. Major players are making investments in AI-based platforms, machine learning technologies and cloud computing infrastructure. Some of the prominent trends are mergers, acquisitions and collaborations between AI startups and well-established pharmaceutical companies. Competitive Landscape focuses on the differentiation based on proprietary algorithms, speed of molecular-discovery, and multi-omics-data-integration. Firms have also been investing in geographic expansion, enhancing the scalability of platforms and widening intellectual property portfolios in order to sustain market leadership and increase the prospects of investment. Some of the key players in the Generative AI in Drug Discovery industry are as:

Insilico Medicine, Atomwise, Recursion Pharmaceuticals, Exscientia, BenevolentAI, Schrödinger, DeepCure, Cloud Pharmaceuticals, Cyclica, Auransa, BioXcel Therapeutics, InSilico Trials, Peptone, Standigm, Iktos

• Software & Platforms (Dominant): Core AI platforms, machine learning algorithms, and cloud computing solutions are extensively used in the areas of molecular design, predictive modeling and virtual screening.
• Hardware: GPUs, high-performance computing systems and specialized servers to perform AI computations.
• Services: Consulting, integration, and training of the seamless deployment of AI.

• Generative Models (Dominant): Variational autoencoders and GANs are algorithms that generate new molecules.
• Predictive Modeling Tools (Fastest-growing): AI models that predict ADMET properties, drug-target interactions, and clinical outcomes.
• Hybrid Systems: This is a mixture of a generative and predictive system that maximizes the efficiency of drug discovery.

• Pharmaceutical & Biotechnology Companies (Dominant): Largescale AI deployment in efficiency of R&D.
• Academic & Research Institutes (Fastest-growing): The application of AI to experimental studies and drug design courses.
• Contract Research Organizations (CROs): Providing AI-based discovery to customers around the world.
• Government, Non-Profit Research Organizations: Funding AI projects to develop drugs in the public health.

Where the Market is Growing Fastest?

The Generative AI in Drug Discovery Market is controlled by North America due to strong pharma R&D framework, early adoption of AI and regulatory encouragement. The market share of Europe is high as a result of well-developed biotech sites and research partnerships. The largest growth is seen in APAC where there is the rise of investments in AI technology, growing pharmaceutical innovation, and government-driven incentives to advance digital drug discovery. The Regional Insights suggest that the prospects in China, India, and Japan are to expand the AI-powered drug pipelines. Emerging markets are utilizing AI to create a gap in R&D, increase cost-efficiency, and increase the rate of clinical trial success.

The following nations and regions will be covered in the report:

•    North America: U.S., Canada and Mexico 
•    Asia Pacific: China, India, Japan, South Korea, Australia, among others
•    Europe: Germany, France, Italy, Spain, UK, Russia, Rest of Europe 
•    Latin America: Brazil, Argentina, Colombia 
•    Middle East & Africa: Saudi Arabia, UAE, South Africa, Israel, Turkey 

1.    Generative AI in Drug Discovery Market:  Market Introduction & Context 
1.1.    Market Definition 
1.2.    Scope of the Study 
1.3.    Research Methodology
1.3.1.    Primary Data Collection
1.3.2.    Secondary Data Sourcing
1.3.3.    External Industry Collaborations
1.3.4.    In-House Research Databases
1.3.5.    Analytical Frameworks & Forecasting End users
1.3.6.    Data Validation and Final Report Publishing
1.4.    Key Assumptions 
1.5.    Market Ecosystem Overview
1.6.    Stakeholder Analysis (Manufacturers, Suppliers, Growers, Distributors, Retailers)
(introduces the report’s scope, methodology, and assumptions to help the client clearly understand the study's coverage, data sources, and reliability)

2.    Generative AI in Drug Discovery Market:  Executive Summary
2.1.    Key Insights & Market Snapshots
2.2.    Analyst Viewpoint 
2.3.    Market Attractiveness Index
(offers a brief yet insightful market summary, giving the client a quick grasp of key trends, market potential, and strategic highlights)

3.    Generative AI in Drug Discovery Market:  Market Dynamics & Outlook
3.1.    Drivers and their impact analysis
3.2.    Restraints and their impact analysis
3.3.    Opportunities and their impact analysis (Emerging Markets, New Product Categories)
3.4.    Patent & Innovation Analysis (2020–2024)
(explains the major drivers, restraints, opportunities, and challenges shaping the market, enabling the client to assess both growth prospects and potential risks)

4.    Generative AI in Drug Discovery Market:  Market Environment & Industry 
4.1.    PESTEL Analysis 
4.1.1.    Political
4.1.2.    Economic  
4.1.3.    Social
4.1.4.    Technological 
4.1.5.    Environmental 
4.1.6.    Legal
4.2.    Porter’s Five Forces Analysis 
4.2.1.    Threat of New Entrants
4.2.2.    Bargaining Power of Buyers
4.2.3.    Bargaining Power of Suppliers
4.2.4.    Substitution Risk
4.2.5.    Competitive Rivalry
4.3.    Pricing Trend Analysis by Region (2024–2030)
4.4.    Value Chain & Supply Chain Analysis 
4.5.    Impact of Digitalization
4.6.      Component & Innovation Landscape
4.7.     Regulatory Framework Analysis
4.7.1.     Global & Regional Regulations 
4.7.1.1.    North America
4.7.1.2.    Europe
4.7.1.3.    APAC
4.7.1.4.    LATAM 
4.7.1.5.    MEA
4.8.    Import/Export Restrictions & Tariff Impact
4.9.    Government Initiatives
4.10.    Impact of Escalating Geopolitical Tensions
(provides an overview of the industry landscape, covering market dynamics, technological advancements, pricing trends, and regulatory influences for decision-making)

5.    Generative AI in Drug Discovery Market – By Component
5.1.    Overview
5.1.1.    Segment Share Analysis, By Component, 2024 & 2035 (%)
5.1.2.    Hardware
5.1.3.    Software & Platforms
5.1.4.    Services
(presents market segmentation By Component, guiding the client on the product categories that are expected to drive demand and shape future revenue streams)

6.    Generative AI in Drug Discovery Market – Type
6.1.    Overview
6.1.1.    Segment Share Analysis, Type, 2024 & 2035 (%)
6.1.2.    Generative Models
6.1.3.    Predictive Modeling Tools
6.1.4.    Hybrid Systems
(breaks down the market Type, assisting the client in identifying material or origin preferences and emerging growth segments)

7.    Generative AI in Drug Discovery Market – By End User
7.1.    Overview
7.1.1.    Segment Share Analysis, By End User, 2024 & 2035 (%)
7.1.2.    Pharmaceutical & Biotechnology Companies
7.1.3.    Academic & Research Institutes
7.1.4.    Contract Research Organizations (CROs)
7.1.5.    Government & Non-Profit Research Organizations
(focuses on market segmentation by End User, helping the client prioritize specific End Users or end-use areas that offer significant business opportunities)

8.    Generative AI in Drug Discovery Market– By Geography
8.1.    Introduction
8.1.1.    Segment Share Analysis, By Geography, 2024 & 2035 (%)
8.2.    North America
8.2.1.    Regional Overview & Trends
8.2.2.    Generative AI in Drug Discovery Key Manufacturers in North America 
8.2.3.    North America Market Size and Forecast, By Country, 2024 - 2035 (US$ Million)
8.2.4.    North America Market Size and Forecast, By Component, 2024 - 2035 (US$ Million)
8.2.5.    North America Market Size and Forecast, Type, 2024 - 2035 (US$ Million)
8.2.6.    North America Market Size and Forecast, By End User, 2024 - 2035 (US$ Million)
8.2.7.    U.S.
8.2.7.1.    Overview
8.2.7.2.    U.S. Market Size and Forecast, By Component, 2024 - 2035 (US$ Million)
8.2.7.3.    U.S. Market Size and Forecast, Type, 2024 - 2035 (US$ Million)
8.2.7.4.    U.S. Market Size and Forecast, By End User, 2024 - 2035 (US$ Million)
8.2.8.    Canada
8.2.8.1.    Overview
8.2.8.2.    Canada Market Size and Forecast, By Component, 2024 - 2035 (US$ Million)
8.2.8.3.    Canada Market Size and Forecast, Type, 2024 - 2035 (US$ Million)
8.2.8.4.    Canada Market Size and Forecast, By End User, 2024 - 2035 (US$ Million)
8.2.9.    Mexico
8.2.9.1.    Overview
8.2.9.2.    Mexico Market Size and Forecast, By Component, 2024 - 2035 (US$ Million)
8.2.9.3.    Mexico Market Size and Forecast, Type, 2024 - 2035 (US$ Million)
8.2.9.4.    Mexico Market Size and Forecast, By End User, 2024 - 2035 (US$ Million)
Note: Similar information and analysis will be provided for all other regions (Europe, APAC, LATAM and MEA) and countries listed in the subsequent sections.
8.3.    Europe
8.3.1.    Germany
8.3.2.    Italy
8.3.3.    United Kingdom
8.3.4.    France
8.3.5.    Russia
8.3.6.    Poland
8.3.7.    Rest of Europe
8.4.    Asia Pacific (APAC)
8.4.1.    India
8.4.2.    China
8.4.3.    Japan
8.4.4.    South Korea
8.4.5.    Australia
8.4.6.    Rest of APAC
8.5.    Latin America
8.5.1.    Brazil
8.5.2.    Argentina
8.5.3.    Colombia
8.5.4.    Rest of LATAM
8.6.    Middle East and Africa
8.6.1.    Israel
8.6.2.    Turkey
8.6.3.    Egypt
8.6.4.    Rest of MEA
(delivers a detailed regional and country-level analysis, supporting the client in recognizing growth hotspots and strategically allocating resources across geographies)

9.    Generative AI in Drug Discovery Market:  Competitive Landscape & Company Profiles
9.1.    Market Share Analysis (2024)
9.2.    Company Positioning Matrix (Leaders, Innovators, Emerging Players)
9.3.    Company Profiles (Key Players: Overview, Products, Strategies, Financials, Recent Developments)
9.3.1.    Insilico Medicine
9.3.2.    Atomwise
9.3.3.    Recursion Pharmaceuticals
9.3.4.    Exscientia
9.3.5.    BenevolentAI
9.3.6.    Schrödinger
9.3.7.    DeepCure
9.3.8.    Cloud Pharmaceuticals
9.3.9.    Cyclica
9.3.10.    Auransa
9.3.11.    BioXcel Therapeutics
9.3.12.    InSilico Trials
9.3.13.    Peptone
9.3.14.    Standigm
9.3.15.    Iktos.
9.3.16.    Others
Note: All company profiles will include details under the standard heads mentioned in section 10.3 - Overview, Products, Strategies, Financials, and Recent Developments. We also offer customization of the company profiling section based on your specific requirements.
(provides an assessment of key competitors, market shares, and strategic developments, giving the client essential insights to benchmark against or collaborate with industry leaders)

10.    Generative AI in Drug Discovery Market:  Future Market Outlook (2025–2035)
10.1.1.    Scenario Analysis (Optimistic, Realistic, Pessimistic)
10.1.2.    Disruptive Technologies Impact
10.1.3.    Emerging Business Trends
10.1.4.    Business Opportunities for startups and existing players
(presents market forecasts and future outlook scenarios, preparing the client for upcoming trends, innovations, and potential shifts in market structure)

11.    Generative AI in Drug Discovery Market:  Strategic Recommendations
(offers strategic recommendations for various stakeholders, enabling the client to make information business decisions that maximize growth and minimize risks)

12.    Generative AI in Drug Discovery Market:  Disclaimer
(states the report’s disclaimers and legal boundaries, ensuring the client understands the terms of use, limitations, and responsibilities associated with the report)

List of Tables

TABLE 1: List of Data Sources
TABLE 2: Market Drivers; Impact Analysis
TABLE 3: Market Restraints; Impact Analysis
TABLE 4: Generative AI in Drug Discovery Market: Component Snapshot (2024)
TABLE 5: Segment Dashboard; Definition and Scope, By Component
TABLE 6: Global Generative AI in Drug Discovery Market, By Component 2022–2035 (USD Billion)
TABLE 7: Generative AI in Drug Discovery Market: Type Snapshot (2024)
TABLE 8: Segment Dashboard; Definition and Scope, Type
TABLE 9: Global Generative AI in Drug Discovery Market, Type 2022–2035 (USD Billion)
TABLE 10: Generative AI in Drug Discovery Market: End User Snapshot (2024)
TABLE 11: Segment Dashboard; Definition and Scope, By End User
TABLE 12: Global Generative AI in Drug Discovery Market, by End User 2022–2035 (USD Billion)
TABLE 13: Generative AI in Drug Discovery Market: Regional Snapshot (2024)
TABLE 14: Segment Dashboard; Definition and Scope, by Region
TABLE 15: Global Generative AI in Drug Discovery Market, by Region 2022–2035 (USD Billion)
TABLE 16: Generative AI in Drug Discovery Market, by Country (NA), 2022–2035 (USD Billion)
TABLE 17: Generative AI in Drug Discovery Market, By Component (NA), 2022–2035 (USD Billion)
TABLE 18: Generative AI in Drug Discovery Market, Type (NA), 2022–2035 (USD Billion)
TABLE 19: Generative AI in Drug Discovery Market, by End User (NA), 2024–2035 (USD Billion)
TABLE 20: U.S. Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 21: U.S. Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 22: U.S. Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 23: Canada Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 24: Canada Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 25: Canada Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 26: Mexico Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 27: Mexico Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 28: Mexico Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 29: Generative AI in Drug Discovery Market, by Country (Europe), 2022–2035 (USD Billion)
TABLE 30: Generative AI in Drug Discovery Market, By Component (Europe), 2022–2035 (USD Billion)
TABLE 31: Generative AI in Drug Discovery Market, Type (Europe), 2022–2035 (USD Billion)
TABLE 32: Generative AI in Drug Discovery Market, by End User (Europe), 2022–2035 (USD Billion)
TABLE 33: Germany Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 34: Germany Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 35: Germany Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 36: Italy Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 37: Italy Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 38: Italy Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 39: United Kingdom Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 40: United Kingdom Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 41: United Kingdom Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 42: France Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 43: France Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 44: France Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 45: Russia Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 46: Russia Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 47: Russia Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 48: Poland Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 49: Poland Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 50: Poland Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 51: Rest of Europe Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 52: Rest of Europe Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 53: Rest of Europe Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 54: Generative AI in Drug Discovery Market, by Country (APAC), 2022–2035 (USD Billion)
TABLE 55: Generative AI in Drug Discovery Market, By Component (APAC), 2022–2035 (USD Billion)
TABLE 56: Generative AI in Drug Discovery Market, Type (APAC), 2022–2035 (USD Billion)
TABLE 57: Generative AI in Drug Discovery Market, by End User (APAC), 2022–2035 (USD Billion)
TABLE 58: India Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 59: India Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 60: India Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 61: China Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 62: China Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 63: China Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 64: Japan Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 65: Japan Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 66: Japan Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 67: South Korea Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 68: South Korea Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 69: South Korea Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 70: Australia Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 71: Australia Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 72: Australia Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 73: Rest of APAC Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 74: Rest of APAC Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 75: Rest of APAC Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 76: Brazil Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 77: Brazil Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 78: Brazil Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 79: Argentina Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 80: Argentina Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 81: Argentina Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 82: Colombia Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 83: Colombia Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 84: Colombia Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 85: Rest of LATAM Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 86: Rest of LATAM Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 87: Rest of LATAM Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 88: Israel Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 89: Israel Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 90: Israel Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 91: Turkey Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 92: Turkey Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 93: Turkey Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 94: Egypt Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 95: Egypt Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 96: Egypt Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)
TABLE 97: Rest of MEA Generative AI in Drug Discovery Market, By Component, 2022–2035 (USD Billion)
TABLE 98: Rest of MEA Generative AI in Drug Discovery Market, Type, 2022–2035 (USD Billion)
TABLE 99: Rest of MEA Generative AI in Drug Discovery Market, by End User, 2022–2035 (USD Billion)

List of Figures

FIGURE 1: Generative AI in Drug Discovery Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: PESTLE Analysis
FIGURE 5: Porter’s Five Forces Analysis
FIGURE 6: Market Attractiveness Analysis
FIGURE 7: Market Dynamics
FIGURE 8: Innovation & Patent Landscape (2020–2024)
FIGURE 9: Competitive Landscape; Key Company Market Share Analysis, 2023
FIGURE 10: Component Segment Market Share Analysis, 2023 & 2035
FIGURE 11: Component Segment Market Size Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 12: Type Segment Market Share Analysis, 2023 & 2035
FIGURE 13: Type Segment Market Size Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 14: End User Segment Market Share Analysis, 2023 & 2035
FIGURE 15: End User Segment Market Size Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 16: Regional Segment Market Share Analysis, 2023 & 2035
FIGURE 17: Regional Segment Market Size Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 18: North America Generative AI in Drug Discovery Market Share and Leading Players, 2024
FIGURE 19: Europe Generative AI in Drug Discovery Market Share and Leading Players, 2024
FIGURE 20: Asia Pacific Generative AI in Drug Discovery Market Share and Leading Players, 2024
FIGURE 21: Latin America Generative AI in Drug Discovery Market Share and Leading Players, 2024
FIGURE 22: Middle East and Africa Generative AI in Drug Discovery Market Share and Leading Players, 2024
FIGURE 23: North America Market Share Analysis by Country, 2024
FIGURE 24: U.S. Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 25: Canada Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 26: Mexico Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 27: Europe Generative AI in Drug Discovery Market Share Analysis by Country, 2023
FIGURE 28: Germany Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 29: Spain Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 30: Italy Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 31: France Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 32: UK Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 33: Russia Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 34: Poland Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 35: Rest of Europe Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 36: Asia Pacific Generative AI in Drug Discovery Market Share Analysis by Country, 2023
FIGURE 37: India Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 38: China Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 39: Japan Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 40: South Korea Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 41: Australia Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 42: Rest of APAC Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 43: Latin America Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 44: Latin America Generative AI in Drug Discovery Market Share Analysis by Country, 2023
FIGURE 45: Brazil Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 46: Argentina Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 47: Colombia Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)
FIGURE 48: Rest of LATAM Generative AI in Drug Discovery Market Size, Forecast and Trend Analysis, 2024 to 2035 (USD Billion)